Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01571752 · ClinicalTrials.gov registry record
Health Outcomes by Neighborhood - Baltimore
A clinical trial, sponsored by National Institute on Drug Abuse (NIDA).
- Completed
- Registry status
- 1,651
- Enrollment target
NCT01571752: Completed study, sponsored by National Institute on Drug Abuse (NIDA).
NCT01571752 is a clinical trial that has completed, run by National Institute on Drug Abuse (NIDA). The registered enrollment target is 1,651 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01571752 has completed, sponsored by National Institute on Drug Abuse (NIDA).
- COMPLETED
- Registry status
- 1,651 participants
- Enrollment target
Study Summary
Background: \- Researchers have been studying patterns of mood and drug use in specific neighborhoods. This study will look at environmental factors that may affect drug use, addiction, and treatment seeking in Baltimore neighborhoods. The results could inform prevention efforts, enhance treatment interventions, and improve substance use outcomes. Objectives: \- To better understand why some people start to use drugs, why some people who use drugs become addicted, and why some people who become addicted enter treatment. Eligibility: \- Individuals at least 18 years of age who are living in the neighborhoods participating in the study. Design: * Participants will be screened with a physical exam and medical history. They will be separated into one of four groups: (1) people who do not use drugs, (2) people who have used drugs in the past, (3) people who are using drugs and want treatment, and (4) people who are using drugs and do not want treatment. * This study will include two outpatient visits about 12 months apart. Each visit will last about 5 hours. Each study visit may be done in 1 day or in 2 days. * At each study visit, participants will provide blood, breath, urine, and saliva samples. They will also have a heart function test and body measurements. They will complete questionnaires about personal and family history. * There will be monthly follow-up phone calls between the two visits.
Primary Outcome
The primary outcome measures will be lifetime substance-misuse history (cross-sectional component) and changes in drug-use status across the 12 months between visits (longitudinal component)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,651 participants |
| Start Date | 2012-07-17 |
What the finished NCT01571752 record still lists
NCT01571752 is an observational study that tracks outcomes without assigning an intervention. Its 1,651 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 0 interventions.
NCT01571752 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01571752 about?
NCT01571752 is a clinical study titled "Health Outcomes by Neighborhood - Baltimore". Background: \- Researchers have been studying patterns of mood and drug use in specific neighborhoods. This study will look at environmental factors that may affect drug use, addiction, and treatment seeking in Baltimore neighborhoods. The results could inform prevention efforts, enhance treatment ...
What is the current status of trial NCT01571752?
This trial is currently completed. The enrollment target is 1,651 participants. The study started on 2012-07-17.
Who is sponsoring clinical trial NCT01571752?
This trial is sponsored by National Institute on Drug Abuse (NIDA), which has 335 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04510129 · 1,650 participants
A Multicenter Cancer Biospecimen Collection Study
- NCT05612750 · 1,650 participants · NA
Comparative Effectiveness of Online 8-session CBT vs. 1-Session Empowered Relief for Chronic Pain - The PROGRESS Study
- NCT06215716 · 1,650 participants · Phase 3
A Study Evaluating Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Fibrosis
- NCT07046260 · 1,650 participants
Prospective Study to Assess a Diagnostic Aid for Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI